1-4 of 4
Robert Bristow
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Report from the SWOG Radiation Oncology Committee: Research Objectives Workshop 2017

Paul Okunieff, Katherine Casey-Sawicki, Natalie A. Lockney, Bradford S. Hoppe, Heiko Enderling, Chelsea Pinnix, James Welsh, Sunil Krishnan, Greg Yothers, Martin Brown, Susan Knox, Robert Bristow, Paul Spellman, Timur Mitin, Nima Nabavizadeh, Jerry Jaboin, H. Charles Manning, Felix Feng, Susan Galbraith, Abhishek A. Solanki, Matthew M. Harkenrider, Richard Tuli, Roy H. Decker, Steven E. Finkelstein, Charles C. Hsu, Chul S. Ha, Reshma Jagsi, Dean Shumway, Megan Daly, Tony J.C. Wang, Thomas J. Fitzgerald, Fran Laurie, David T. Marshall, David Raben, Louis Constine, Charles R. Thomas, Jr, Lisa A. Kachnic
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (15): 3500–3509.
https://doi.org/10.1158/1078-0432.CCR-17-3202
Published: 31 July 2018
View articletitled, Report from the SWOG Radiation Oncology Committee: Research Objectives Workshop 2017
Open the PDF for Report from the SWOG Radiation Oncology Committee: Research Objectives Workshop 2017 in another window
Journal Articles

Abstract TMEM-021: CORRELATION BETWEEN DRUG SENSITIVITY AND METABOLOMIC SIGNATURES WITH OBJECTIVE RESPONSE (OR), TIME TO PROGRESSION (TTP), AND OVERALL SURVIVAL (OS) IN ADVANCED EPITHELIAL OVARIAN CANCER (EOC): A PHASE II STUDY

Paulo D'Amora, MD, PhD, Ismael DCG Silva, MD, PhD; 142 MD, PhD, Marcia Batista Salzgeber, Manoel JBC Girão, MD, PhD, Robert Bristow, MD, Steven Evans, BS, MA, Philip J. DiSaia, MD, Robert Nagourney, MD
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (11_Supplement): TMEM-021.
https://doi.org/10.1158/1557-3265.OVCASYMP16-TMEM-021
Published: 31 May 2017
View articletitled, Abstract TMEM-021: CORRELATION BETWEEN DRUG SENSITIVITY AND METABOLOMIC SIGNATURES WITH OBJECTIVE RESPONSE (OR), TIME TO PROGRESSION (TTP), AND OVERALL SURVIVAL (OS) IN ADVANCED EPITHELIAL OVARIAN CANCER (EOC): A PHASE II STUDY
Journal Articles

Tumor Hypoxia Predicts Biochemical Failure following Radiotherapy for Clinically Localized Prostate Cancer

Michael Milosevic, Padraig Warde, Cynthia Ménard, Peter Chung, Ants Toi, Adrian Ishkanian, Michael McLean, Melania Pintilie, Jenna Sykes, Mary Gospodarowicz, Charles Catton, Richard P. Hill, Robert Bristow
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (7): 2108–2114.
https://doi.org/10.1158/1078-0432.CCR-11-2711
Published: 01 April 2012
View articletitled, Tumor Hypoxia Predicts Biochemical Failure following Radiotherapy for Clinically Localized Prostate Cancer
Open the PDF for Tumor Hypoxia Predicts Biochemical Failure following Radiotherapy for Clinically Localized Prostate Cancer in another window
Journal Articles

Characterization of Active Mitogen-Activated Protein Kinase in Ovarian Serous Carcinomas

Chih-Yi Hsu, Robert Bristow, Moon Seok Cha, Brant G. Wang, Chung-Liang Ho, Robert J. Kurman, Tian-Li Wang, Ie-Ming Shih
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (19): 6432–6436.
https://doi.org/10.1158/1078-0432.CCR-04-0893
Published: 08 October 2004
View articletitled, Characterization of Active Mitogen-Activated Protein Kinase in Ovarian Serous Carcinomas
Open the PDF for Characterization of Active Mitogen-Activated Protein Kinase in Ovarian Serous Carcinomas in another window